Letter to FDA Opposing Approval of Bedaquiline
Public Citizen strongly opposes the accelerated approval of bedaquiline because patients taking the drug, in addition to standard TB treatment, during a phase 2 clinical trial were five times likelier to die than those who took a placebo.
January 16, 2013: FDA response to our letter